Results 41 to 50 of about 7,517 (258)

Extracorporeal photopheresis and the cellular mechanisms: Effects of 8‐methoxypsoralen and UVA treatment on red blood cells, platelets and reactive oxygen species

open access: yesVox Sanguinis, 2023
Extracorporeal photopheresis (ECP) is a widespread cellular therapy for graft‐versus‐host disease, autoimmune diseases and Sézary disease. One of the main effects of ECP is the apoptosis of leukocytes, but the therapeutic mechanisms are not completely ...
H. Budde   +4 more
semanticscholar   +1 more source

Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape

open access: yesLeukemia, 2022
Patients with steroid-refractory graft-versus-host disease (GvHD) are known to have a poor prognosis and for decades no approved drug has been available to treat this serious condition.
H. Greinix, F. Ayuk, R. Zeiser
semanticscholar   +1 more source

Regulatory T-cells in chronic graft-versus-host disease following extracorporeal photopheresis: correlation with skin and global organ responses, and ability to taper steroids [PDF]

open access: yes, 2017
Background: Induction of immune tolerance by an increase in regulatory T (Treg) cells after extracorporeal photopheresis (ECP) is thought to contribute to how ECP exerts its therapeutic effect in patients with chronic graft-versus-host disease (cGvHD ...
Denney, H.A.   +4 more
core   +1 more source

THE PATHOGENETIC SUBSTANTIATION OF EFFICIENCY OF PHOTOPHERESIS IN ATYPICAL VARIANTS OF LICHEN PLANUS

open access: yesVestnik Dermatologii i Venerologii, 2018
Lichen planus (LP) is an autoimmune disorder which is characterized by long lasting, recurrent course of a disease and by poor response to treatment (including systemic corticosteroids and cytostatics).
Yulia V. Molochkova   +4 more
doaj   +1 more source

Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction [PDF]

open access: yes, 2021
BACKGROUND: This study was designed to prospectively evaluate the efficacy of extracorporeal photopheresis (ECP) to attenuate the rate of decline of FEV STUDY DESIGN AND METHODS: Subjects from 10 lung transplant centres were assigned to ECP treatment or ...
Atkinson, Jeff   +8 more
core   +2 more sources

APPLICATION OF EXTRACORPOREAL PHOTOCHEMOTHERAPY IN SKIN LYMPHOMAS AND TRANSPLANTATION OF SOLID ORGANS

open access: yesAlʹmanah Kliničeskoj Mediciny, 2016
The new immunotherapeutic method is presented in the review - an extracorporeal photochemotherapy. The questions concerning its application in the T-cellular lymphoma of skin and transplantation of solid bodies are discussed.
A. V. Kildyushevsky   +3 more
doaj   +1 more source

Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation [PDF]

open access: yes, 2023
Background: Extracorporeal photopheresis (ECP) induces immunological changes that lead to a reduced risk of transplant rejection. The aim of the present study was to determine optimum conditions for ECP treatment by analyzing a variety of ...
Ayuk, Francis Ayuketang   +9 more
core   +1 more source

EXTRA-CORPOREAL PHOTOCHEMOTHERAPY IN THE TREATMENT OF LYMPHOMATOID PAPULOSIS AND FOLLICULOTROPIC MYCOSIS FUNGOIDES: CASE REPORTS

open access: yesAlʹmanah Kliničeskoj Mediciny, 2016
Aim: To assess clinical efficacy of extra-corporeal photochemotherapy (EPCT) in the treatment of rare lymphomas  – lymphomatoid papulosis and folliculotropic mycosis fungoides.
A. V. Kil’dyushevskiy   +2 more
doaj   +1 more source

TREATMENT OF THE TUMOR STAGE OF MYCOSIS FUNGOIDES WITH EXTRACORPOREAL PHOTOCHEMOTHERAPY (A CASE DESCRIPT

open access: yesAlʹmanah Kliničeskoj Mediciny, 2016
The article describes treatment experience with a  tumor stage of mycosis fungoides patient treated with extracorporeal photochemotherapy that showed high clinical efficacy. The patient responded with significant regression of the skin elements after two
V. A. Molochkov   +2 more
doaj   +1 more source

A review on newer therapeutic modalities for immune-mediated oral mucosal disorders: A start from the dead end

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2015
The immune-mediated oral mucosal lesions pose a challenge to the oral physicians owing to their preplexing diagnosis and management. Steroids are the first line of treatment for these diseases, but they have their limitations.
Bharati A Patil   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy